Related Experiment Video
Updated: May 15, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Cyclin-dependent kinase 4 signaling acts as a molecular switch between syngenic differentiation and neural
Janet Lee1, Jeong-Hwa Baek, Kyu-Sil Choi
1Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi, Korea.
Abstract:
Multipotent mesenchymal stem/stromal cells (MSCs) are capable of differentiating into a variety of cell types from different germ layers. However, the molecular and biochemical mechanisms underlying the transdifferentiation of MSCs into specific cell types still need to be elucidated. In this study, we unexpectedly found that treatment of human adipose- and bone marrow-derived MSCs with cyclin-dependent kinase (CDK) inhibitor, in particular CDK4 inhibitor, selectively led to transdifferentiation into neural cells with a high frequency. Specifically, targeted inhibition of CDK4 expression using recombinant adenovial shRNA induced the neural transdifferentiation of human MSCs. However, the inhibition of CDK4 activity attenuated the syngenic differentiation of human adipose-derived MSCs. Importantly, the forced regulation of CDK4 activity showed reciprocal reversibility between neural differentiation and dedifferentiation of human MSCs. Together, these results provide novel molecular evidence underlying the neural transdifferentiation of human MSCs; in addition, CDK4 signaling appears to act as a molecular switch from syngenic differentiation to neural transdifferentiation of human MSCs.
Insights
Cyclin-dependent kinase (CDK) inhibitors, specifically CDK4 inhibitors, promote neural cell transdifferentiation in human mesenchymal stem/stromal cells (MSCs). CDK4 signaling acts as a switch, controlling neural versus syngenic differentiation in MSCs.
Area of Science:
- Stem cell biology
- Molecular mechanisms of cell differentiation
- Neuroscience
Background:
- Multipotent mesenchymal stem/stromal cells (MSCs) possess differentiation potential into various cell types.
- The precise molecular pathways governing MSC transdifferentiation remain incompletely understood.
- Understanding these mechanisms is crucial for regenerative medicine and cell-based therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms controlling MSC transdifferentiation.
- To investigate the role of cyclin-dependent kinase (CDK) signaling in MSC differentiation.
- To explore the potential of CDK inhibitors in directing MSC fate towards neural lineages.
Main Methods:
- Treatment of human adipose- and bone marrow-derived MSCs with CDK inhibitors, particularly CDK4 inhibitors.
- Utilizing recombinant adenoviral shRNA to specifically inhibit CDK4 expression.
- Assessing the frequency and characteristics of neural transdifferentiation.
- Evaluating the impact of CDK4 inhibition on syngenic differentiation.
- Investigating the reversibility of differentiation states through forced regulation of CDK4 activity.
Main Results:
- CDK4 inhibition selectively induced neural transdifferentiation of human MSCs at high frequencies.
- Targeted inhibition of CDK4 expression via shRNA promoted neural differentiation.
- Inhibition of CDK4 activity attenuated the syngenic differentiation capacity of MSCs.
- Modulation of CDK4 activity demonstrated reciprocal control over neural differentiation and dedifferentiation.
Conclusions:
- CDK4 signaling acts as a critical molecular switch regulating the balance between syngenic and neural transdifferentiation in human MSCs.
- Novel molecular evidence supports the role of CDK4 in directing MSC fate towards neural lineages.
- These findings offer new insights into the control of stem cell differentiation for potential therapeutic applications.
More Related Videos
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Somatic to iPS Cell Reprogramming
MAPK Signaling Cascades
Positive Regulator Molecules
Positive Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

